Coronavirus: Ivermectin

(asked on 9th March 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of Ivermectin as a prophylactic and treatment for covid-19; and what plans his Department has to use Ivermectin to treat covid-19.


Answered by
Nadine Dorries Portrait
Nadine Dorries
This question was answered on 17th March 2021

Currently, ivermectin for oral use is not a licensed human medicine in the United Kingdom. For ivermectin to be granted a marketing authorisation in the UK, an application must be submitted to the Medicines and Healthcare products Regulatory Agency (MHRA) for review. The MHRA has processes in place to expedite such an application, and assess this for quality, efficacy and safety.

The MHRA is aware that ivermectin, administered orally, is being studied for safety and efficacy in numerous clinical trials worldwide and is used in some countries in the treatment of COVID-19. While some studies have reported findings, other large studies are still on-going.

Reticulating Splines